As a heterogeneous disease, breast cancer is clinically classified by taking into account the expression of estrogen receptor alpha (ERα), progesterone receptor (PR), and the presence/amplification status of the oncogenic human epidermal growth factor receptor 2 (HER2) [1]. The gene discussed is ERBB2; the disease is breast carcinoma.